<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05094492</url>
  </required_header>
  <id_info>
    <org_study_id>p11-4</org_study_id>
    <nct_id>NCT05094492</nct_id>
  </id_info>
  <brief_title>Evaluation of Remineralization Potential of Self Assembling Peptide Combined With Fluoride</brief_title>
  <official_title>Evaluation of Remineralization Potential of Self Assembling Peptide P11-4 Combined With Fluoride Compared to Fluoride Varnish in Management of Incipient Carious Lesions Using Laser Fluorescence: Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Self-assembling peptide (P11-4) exhibited an outstanding ability for biomimetic&#xD;
      re-mineralization of incipient enamel carious lesions. It creates a 3D matrix within the&#xD;
      subsurface of carious lesions, allowing de novo formation of Hydroxyapatite crystals, thus&#xD;
      enabling guided enamel regeneration of the demineralized enamel structure. Addition of&#xD;
      fluoride to P11-4 may have a synergistic effect on the remineralization potential.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized clinical trial, with parallel study design, 1:1 allocation ratio&#xD;
      and superiority framework. The aim of the current trial is to evaluate remineralization&#xD;
      potential of P11-4 combined with fluoride compared to fluoride varnish in management of&#xD;
      incipient white spot carious lesions. Progress of the lesions will be assessed using laser&#xD;
      fluorescence (DIAGNOdent).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 30, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Remineralization</measure>
    <time_frame>6 months</time_frame>
    <description>measuring carious lesion development using DIAGNOdent laser fluorescence (scores from 0 to 99) according to progression of the carious lesion</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">58</enrollment>
  <condition>Caries; Initial</condition>
  <arm_group>
    <arm_group_label>Self assembling peptide P11-4 with fluoride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>P11-4 forms a 3D matrix within subsurface of incipient carious lesions , allowing formation of new hydroxyapatite crystal facilitating guided regeneration of enamel lesions. Combination with fluoride will have a synergistic effect on remineralization potential</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fluoride varnish</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gold standard agent for remineralization of incipient carious lesions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Curodont Repair Fluoride Plus</intervention_name>
    <description>P11-4 self assembling peptide combined with fluoride</description>
    <arm_group_label>Self assembling peptide P11-4 with fluoride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bifluorid 10 fluoride varnish</intervention_name>
    <description>5% Sodium Fluoride varnish (equal to 22,600 ppm fluoride)</description>
    <arm_group_label>Fluoride varnish</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Active carious white spot lesions.&#xD;
&#xD;
          -  Patient compliance.&#xD;
&#xD;
          -  Controlled oral hygiene condition.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participant in another trial.&#xD;
&#xD;
          -  Non carious lesions.&#xD;
&#xD;
          -  Systemic diseases or concomitant medication affecting salivary flow.&#xD;
&#xD;
          -  Cavitation of carious lesions.&#xD;
&#xD;
          -  Parafunctional habits.&#xD;
&#xD;
          -  Pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar O Shaalan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer, Conservative Dentistry Department, Faculty of Dentistry, Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Omar O Shaalan, PhD</last_name>
    <phone>00201122665661</phone>
    <email>omar.shaalan@dentistry.cu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Dentistry, Cairo University</name>
      <address>
        <city>Cairo</city>
        <state>El Manial</state>
        <zip>11553</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>Omar O Shaalan, Phd</last_name>
      <phone>00201122665661</phone>
      <email>omar.shaalan@dentistry.cu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 13, 2021</study_first_submitted>
  <study_first_submitted_qc>October 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2021</study_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Omar Osama Shaalan</investigator_full_name>
    <investigator_title>Lecturer, Conservative Dentistry Department, Faculty of Dentistry</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Fluorides, Topical</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

